Only from an academic point of view. I think it cannot be other than a negative result and also think it is pretty easy to get a good estimate on how negative cash flow will be for the quarter. As I've said before I don't think they will be able to claim they have reached nameplate so I'm not expecting any good news surprises. The academic bit I will be interested in is to see how the market reacts to the result. If it were an efficient market, all these things should be factored in but my guess is that some retail holders will push the panic button and therefore it may provide a buying opportunity. All IMO and DYOR.
- Forums
- ASX - By Stock
- E25
- Ann: Revised Shipping Strategy Yields Substantial Cost Reduction
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Ann: Revised Shipping Strategy Yields Substantial Cost Reduction, page-176
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
3 | 28857 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online